Fortrea Holdings Inc. (FTRE)
Services-Medical Laboratories
Latest Price
$19.17
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
5.62
P/B Ratio
3.41
Valuation metrics
adjust assumptions →Base FCF: $127M (median of recent 3yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$13.90
27% downside
Institutional Ownership
99.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15.15M | $142.0M | 16.02% | +386.1K | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 8.10M | $76.0M | 8.56% | -174.1K | 2026-03-31 |
| Sessa Capital IM, L.P. | 4.59M | $43.0M | 4.86% | +600.0K | 2026-03-31 |
| STATE STREET CORP | 4.11M | $38.0M | 4.34% | -1.5K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.04M | $38.0M | 4.27% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.70M | $34.0M | 3.91% | -- | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 3.30M | $30.0M | 3.49% | +310.4K | 2026-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.21M | $30.0M | 3.39% | -11.4K | 2026-03-31 |
| DEUTSCHE BANK AG\ | 2.57M | $24.0M | 2.72% | +13.1K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.37M | $22.0M | 2.50% | +87.5K | 2026-03-31 |